1. A phase II study of the insulin-like growth factor type I receptor inhibitor IMC-A12 in patients with metastatic uveal melanoma. Issue 6 (December 2020) Authors: Mattei, Jane; Ballhausen, Alexej; Bassett, Roland; Shephard, Michael; Chattopadhyay, Chandrani; Hudgens, Courtney; Tetzlaff, Michael; Woodman, Scott; Sato, Takami; Patel, Sapna P. Journal: Melanoma research Issue: Volume 30:Issue 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗